U.S. sales of Pfizer's Comirnaty shots have taken a nosedive since the Trump administration updated its immunization schedules last month and dropped the universal collective recommendations for COVID-19 vaccines.The pharmaceutical company's revenues for the third quarter of 2025 are down 6% — amo......